| 36477009 | Acetophenone protection against cisplatin-induced end-organ damage. | Transl Oncol | 2023 |
| 37526394 | Drivers of Differential Time to Diagnosis in Pediatric ALL Tied to Race and Ethnicity. | J Pediatr Hematol Oncol | 2023 |
| 37424864 | Breaking down the tumor immune infiltration within pediatric sarcomas. | Front Endocrinol (Lausanne) | 2023 |
| 37314946 | Respiratory Failure Due to Idiopathic Pneumonia Syndrome in a Pediatric Patient After Recipient-derived Allogeneic Chimeric Antigen Receptor T-Cell Therapy. | J Pediatr Hematol Oncol | 2023 |
| 37333164 | RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma. | bioRxiv | 2023 |
| 34767308 | SARS-CoV-2 as a mimicker of pulmonary metastasis in osteosarcoma. | Pediatr Blood Cancer | 2022 |
| 35772048 | Social Genomics as a Framework for Understanding Health Disparities Among Adolescent and Young Adult Cancer Survivors: A Commentary. | JCO Precis Oncol | 2022 |
| 35219358 | Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave. | Cancer Cell | 2022 |
| 35278029 | Pembrolizumab as maintenance therapy for malignant rhabdoid tumor. | Pediatr Blood Cancer | 2022 |
| 35262780 | Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial. | Cancer Immunol Immunother | 2022 |
| 32725878 | Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID-19. | Pediatr Blood Cancer | 2021 |
| 33887462 | Circulating Plasma Tumor DNA Is Superior to Plasma Tumor RNA Detection in Ewing Sarcoma Patients: ptDNA and ptRNA in Ewing Sarcoma. | J Mol Diagn | 2021 |
| 33975179 | XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB. | Transl Oncol | 2021 |
| 32852398 | Respiratory Failure in a Child With Pulmonary Metastatic Osteosarcoma and COVID-19. | J Pediatr Hematol Oncol | 2021 |
| 32815877 | The Utility of 18FDG PET/CT Versus Bone Scan for Identification of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Literature. | J Pediatr Hematol Oncol | 2021 |
| 32398945 | Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung. | Sarcoma | 2020 |
| 31978392 | Enolate-forming compounds provide protection from platinum neurotoxicity. | Chem Biol Interact | 2020 |
| 32623326 | Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcoma. | Transl Oncol | 2020 |
| 32386107 | Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. | Pediatr Blood Cancer | 2020 |
| 32176331 | An evolutionary framework for treating pediatric sarcomas. | Cancer | 2020 |
| 32561749 | A clinically and genomically annotated nerve sheath tumor biospecimen repository. | Sci Data | 2020 |
| 28905489 | Consensus and controversies regarding the treatment of rhabdomyosarcoma. | Pediatr Blood Cancer | 2018 |
| 29933069 | Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. | Biol Blood Marrow Transplant | 2018 |
| 30478297 | Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibition. | Cell Death Dis | 2018 |
| 30450160 | Knock-in of the <i>Wt1</i> R394W mutation causes MDS and cooperates with <i>Flt3/ITD</i> to drive aggressive myeloid neoplasms in mice. | Oncotarget | 2018 |
| 30410720 | A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas. | Clin Sarcoma Res | 2018 |
| 29710216 | Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib. | JAMA Oncol | 2018 |
| 27888014 | Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies. | Biol Blood Marrow Transplant | 2017 |
| 30003184 | Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. | JCO Precis Oncol | 2017 |
| 28408855 | Targeted therapy for soft tissue sarcomas in adolescents and young adults. | Adolesc Health Med Ther | 2017 |
| 28453898 | Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy. | Pediatr Blood Cancer | 2017 |
| 28323337 | Treatment pathway of bone sarcoma in children, adolescents, and young adults. | Cancer | 2017 |
| 29108279 | Size-based detection of sarcoma circulating tumor cells and cell clusters. | Oncotarget | 2017 |
| 29108227 | Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma. | Oncotarget | 2017 |
| 29100387 | Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties. | Oncotarget | 2017 |
| 28807769 | Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients. | Biol Blood Marrow Transplant | 2017 |
| 28631382 | A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. | Int J Cancer | 2017 |
| 27696380 | Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. | Cancer | 2017 |
| 26864479 | Automated Functional Imaging by 2D Speckle Tracking Echocardiography Reveals High Incidence of Abnormal Longitudinal Strain in a Cohort of Pediatric Oncology Patients. | Pediatr Blood Cancer | 2016 |
| 26343947 | Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies. | Biol Blood Marrow Transplant | 2016 |
| 26364611 | RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma. | Oncogene | 2016 |
| 27634018 | Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse. | Biol Blood Marrow Transplant | 2016 |
| 27594960 | Desmoplastic small round cell tumor: postoperative retroperitoneal mass. | Radiol Case Rep | 2016 |
| 27351911 | Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA. | Cancer | 2016 |
| 27467367 | High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia. | J Pediatr Hematol Oncol | 2016 |
| 26860634 | Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders. | Biol Blood Marrow Transplant | 2016 |
| 26710211 | SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma. | Cancer | 2016 |
| 27049730 | A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model. | Oncotarget | 2016 |
| 25794157 | Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells. | PLoS One | 2015 |
| 26278104 | An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis. | Clin Exp Metastasis | 2015 |